Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) | PAR-22-213 | NIA | This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects… More | ||
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) | RFA-AG-24-001 | NIA | This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to develop, or renew, an Alzheimer's Disease Research Center (ADRC). The National Institute on Aging… More | ||
| NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) | PAR-24-120 | NIA | The purpose of the NIA Career Transition Award (CTA) is to facilitate the transition of mentored researchers to tenure-track faculty conducting research that advances the mission of NIA. This three-… More | ||
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) | PAR-23-054 | NIA | This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations… | ||
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) | PAR-23-053 | NIA | This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations… More | ||
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) | PAR-23-057 | NIA | This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site interventional clinical trials (all phases). The trials should be hypothesis-… More | ||
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) | PAR-23-258 | NIA | The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment ofeffective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for usein… More | ||
| Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) | PAR-23-179 | NIA | This Small Research Grant (R03) will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer… More | ||
| NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) | PAR-24-135 | NIA | ThisNotice of Funding Opportunity (NOFO) invites R25 applications to support the development and implementation of research education programs forundergraduate students from diverse backgrounds,… More | ||
| Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) | PAR-24-121 | NIA | The specific purpose of this NOFO is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-… More |